BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23819180)

  • 1. Dabigatran and mechanical valves: less effective and more risky than warfarin.
    Prescrire Int; 2013 May; 22(138):128. PubMed ID: 23819180
    [No Abstract]   [Full Text] [Related]  

  • 2. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.
    Nagarakanti R; Ezekowitz MD; Oldgren J; Yang S; Chernick M; Aikens TH; Flaker G; Brugada J; Kamensky G; Parekh A; Reilly PA; Yusuf S; Connolly SJ
    Circulation; 2011 Jan; 123(2):131-6. PubMed ID: 21200007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dabigatran for stroke prevention in all patients with atrial fibrillation?
    Hunchuck JE; Lake JD
    Pharmacotherapy; 2011 Aug; 31(8):725-8. PubMed ID: 21923597
    [No Abstract]   [Full Text] [Related]  

  • 4. Dabigatran (Pradaxa): deep vein thrombosis and pulmonary embolism. Warfarin remains the standard drug.
    Prescrire Int; 2015 Jun; 24(161):150. PubMed ID: 26436165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Edwards DB; Silverberg J
    Ann Intern Med; 2011 Apr; 154(8):570; author reply 570-1. PubMed ID: 21502658
    [No Abstract]   [Full Text] [Related]  

  • 6. Dabigatran: will it change clinical practice?
    Wartak SA; Bartholomew JR
    Cleve Clin J Med; 2011 Oct; 78(10):657-64. PubMed ID: 21968472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Massive left atrial thrombus in a patient with rheumatic mitral stenosis and atrial fibrillation while anticoagulated with dabigatran.
    Luis SA; Poon K; Luis C; Shukla A; Bett N; Hamilton-Craig C
    Circ Cardiovasc Imaging; 2013 May; 6(3):491-2. PubMed ID: 23696587
    [No Abstract]   [Full Text] [Related]  

  • 8. Next generation anticoagulants may push warfarin to the wayside.
    Kirsch B
    Manag Care; 2011 Feb; 20(2):33-6. PubMed ID: 21428128
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.
    Shah SV; Gage BF
    Circulation; 2011 Jun; 123(22):2562-70. PubMed ID: 21606397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S; Ansell J
    Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.
    Prescrire Int; 2012 Feb; 21(124):33-6. PubMed ID: 22413715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis.
    Ali A; Bailey C; Abdelhafiz AH
    Age Ageing; 2012 Sep; 41(5):681-4. PubMed ID: 22378612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fewer strokes, lower mortality. Large general practice studies confirm good safety profile of dabigatran].
    Einecke D
    MMW Fortschr Med; 2014 Dec; 156(21-22):28, 30. PubMed ID: 25608388
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of dabigatran immediately after atrial fibrillation ablation.
    Winkle RA; Mead RH; Engel G; Kong MH; Patrawala RA
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):264-8. PubMed ID: 21955008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal association of mechanical valve thrombosis with dabigatran: a report of two cases.
    Atar S; Wishniak A; Shturman A; Shtiwi S; Brezins M
    Chest; 2013 Jul; 144(1):327-328. PubMed ID: 23880682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dabigatran versus warfarin after mechanical mitral valve replacement in the swine model.
    Schomburg JL; Medina EM; Lahti MT; Bianco RW
    J Invest Surg; 2012 Jun; 25(3):150-5. PubMed ID: 22583010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.
    Hohnloser SH; Oldgren J; Yang S; Wallentin L; Ezekowitz M; Reilly P; Eikelboom J; Brueckmann M; Yusuf S; Connolly SJ
    Circulation; 2012 Feb; 125(5):669-76. PubMed ID: 22215856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dabigatran - neurosurgical anathema?
    Thomas PA; Schaerf NB; Rosenfeld JV
    Med J Aust; 2013 Aug; 199(4):238-40. PubMed ID: 23984772
    [No Abstract]   [Full Text] [Related]  

  • 19. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
    Healey JS; Eikelboom J; Douketis J; Wallentin L; Oldgren J; Yang S; Themeles E; Heidbuchel H; Avezum A; Reilly P; Connolly SJ; Yusuf S; Ezekowitz M;
    Circulation; 2012 Jul; 126(3):343-8. PubMed ID: 22700854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombosis on a Mechanical Aortic Valve whilst Anti-coagulated With Dabigatran.
    Stewart RA; Astell H; Young L; White HD
    Heart Lung Circ; 2012 Jan; 21(1):53-5. PubMed ID: 21937274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.